Please wait a minute...
Clinical and Experimental Obstetrics & Gynecology  2019, Vol. 46 Issue (6): 903-905    DOI: 10.12891/ceog4869.2019
Original Research Previous articles | Next articles
Maternal mortality in Serbia - revisited
M. Petronijevic1, 2, *(), S. V. Petronijevic1, 2, I. Ivan3, K. Maja3, D. Bratic2
1Faculty of Medicine, University of Belgrade, Belgrade, Serbia
2Clinic of Gynecology and Obstetrics, Clinical Center of Serbia, Belgrade, Serbia
3Institute of Public Health of Serbia "Dr. Milan Jovanovic Batut", Belgrade, Serbia
Download:  PDF(237KB)  ( 204 ) Full text   ( 9 )
Export:  BibTeX | EndNote (RIS)      
Abstract  

Purpose: The purpose of this investigation was to analyze maternal mortality in Republic of Serbia. Materials and Methods: Maternal mortality in Republic of Serbia was analysed in two periods, 2007-2011 and 2012-2016. Sources of data for this analysis were: Population statistics notices of Statistical Office of Serbia and Health Statistical Yearbooks of Republic of Serbia Institute of Public Health of Serbia "Dr. Milan Jovanovic Batut". Results: Maternal mortality ratio in Serbia, although relatively high, in the last six years shows a declining trend (from 14.9 in 2012 to 10.8 per 100,000 live births in 2016). Conclusion: To promote and preserve the health of women of childbearing age, it is necessary to insure greater social and economic security of all women, especially in the period of maternity, pro-natal policy of the state, and the protection of the family. A significant reduction in maternal mortality can be achieved by early diagnosis, prompt treatment, and rehabilitation after certain illnesses.

Key words:  Maternal      Mortality      Serbia      Childbearing age     
Published:  10 December 2019     
*Corresponding Author(s):  M. PETRONIJEVIC     E-mail:  ordinacija.petronijevic@gmail.com

Cite this article: 

M. Petronijevic, S. V. Petronijevic, I. Ivan, K. Maja, D. Bratic. Maternal mortality in Serbia - revisited. Clinical and Experimental Obstetrics & Gynecology, 2019, 46(6): 903-905.

URL: 

https://ceog.imrpress.com/EN/10.12891/ceog4869.2019     OR     https://ceog.imrpress.com/EN/Y2019/V46/I6/903

[1] S. Y. Jung, S. J. Chon, R. S. Lee, E. Y. Woo, J. S. Lee, S. Y. Kim. Difference in pregnancy outcomes between primiparous and multiparous women older than 40 years[J]. Clinical and Experimental Obstetrics & Gynecology, 2020, 47(2): 243-247.
[2] T. T. Kitova, B. D. Kitov, E. H. Uchikova, N. T. Ahmad. Maternal age - a risk factor for congenital hydrocephalus[J]. Clinical and Experimental Obstetrics & Gynecology, 2020, 47(2): 257-261.
[3] S. J. Knight, A. D. Smith, H. Kim, A. C. Collier. Human placental suppressors of cytokine signalling (SOCS) and inflammatory cytokines are dysregulated in assisted reproduction, advanced maternal age and pre-term birth[J]. Clinical and Experimental Obstetrics & Gynecology, 2020, 47(2): 277-286.
[4] N. Al-Husban, O. Al-Kuran, M. Khadra, K. Fram. Thrombocytopenia in pregnancy; prevalence, causes and fetomaternal outcome[J]. Clinical and Experimental Obstetrics & Gynecology, 2020, 47(1): 21-26.
[5] A.P. Londero, S. Visentin, L. Marin, M. C. Bongiorno, D. Visentin, S. Bertozzi, E. Cosmi, A Cagnacci, L. Driul. Second trimester prediction of small for gestational age and intrauterine growth restriction[J]. Clinical and Experimental Obstetrics & Gynecology, 2020, 47(1): 70-74.
[6] Qianhong Liang, Wei Gong, Dongming Zheng, Risheng Zhong, Yunjie Wen, Xiaodan Wang. Preliminary analysis of risk factors for congenital heart disease: a retrospective review of 145 cases in a single institution[J]. Clinical and Experimental Obstetrics & Gynecology, 2019, 46(5): 713-722.
[7] Woo Jin Kim, Young-Hoon Joo, Kyung-do Han, Kyoung Ho Park. Does maternal age at childbirth and parity have any effect on hearing loss? The 2008-2012 Korean National Health and Nutrition Examination Survey[J]. Clinical and Experimental Obstetrics & Gynecology, 2019, 46(3): 383-386.
[8] Y. Gao, P. Wang, T. Zou, Z. Zhang, W. Liang. Increased Th17 and reduced Treg cells in patients with unexplained recurrent spontaneous abortion[J]. Clinical and Experimental Obstetrics & Gynecology, 2019, 46(3): 458-460.
[9] M. Collict, Y. Mucat Baron, M. Gatt, N. Calleja. Advanced maternal age and neonatal outcomes in Malta[J]. Clinical and Experimental Obstetrics & Gynecology, 2019, 46(2): 265-269.
[10] B. Díaz-Rabasa, R. Crespo Esteras, A. Agustín-Oliva, R.A. Laborda Gotor, P. Tobías González, C. De Bonrostro Torralba, S. Castán Mateo. Has advanced maternal age a real impact on intrapartum caesarean rate?[J]. Clinical and Experimental Obstetrics & Gynecology, 2019, 46(1): 55-59.
[11] A. Simsek, S. Uludag, A. Tuten, A. S. Acikgoz, S. Uludag. Maternal and perinatal outcomes in early onset and late onset preeclampsia[J]. Clinical and Experimental Obstetrics & Gynecology, 2018, 45(6): 837-841.
[12] K. Miura, A. Higashijima, Y. Hasegawa, S. Miura, KI. Yoshiura, H. Masuzaki. Decreased cell-free but not exosomal miR-518b in maternal plasma is caused by amniocentesis[J]. Clinical and Experimental Obstetrics & Gynecology, 2018, 45(6): 875-879.
[13] K. Miura, A. Higashijima, Y. Hasegawa, S. Miura, A. Yoshida, H. Masuzaki. Decreased plasma concentrations of pregnancy-associated placenta-specific microRNAs in pregnancies with a diagnosis of fetal trisomy 18[J]. Clinical and Experimental Obstetrics & Gynecology, 2018, 45(6): 897-900.
[14] I. Babović, M. Matić, S. Plešinac. Woman with Marfan syndrome in pregnancy: good maternal and fetal outcome – a case report and literature review[J]. Clinical and Experimental Obstetrics & Gynecology, 2018, 45(6): 920-923.
[15] G. Genest, B. Elliott, K. Spitzer, C. A. Laskin, W. Buckett, L. Lapensée, I.J, Kadoch, P. Gol. Intravenous Immunoglobulin (IVIg) for unexplained infertility: a case series[J]. Clinical and Experimental Obstetrics & Gynecology, 2018, 45(5): 699-701.
No Suggested Reading articles found!